Related Experiment Video
Updated: Jul 3, 2026
05:46
Rapid Screening of HIV Reverse Transcriptase and Integrase Inhibitors
Published on: April 9, 2014
MAPPIT (MAmmalian Protein-Protein Interaction Trap) as a tool to study HIV reverse transcriptase dimerization in
Els Pattyn1, Delphine Lavens, José Van der Heyden
1Department of Medical Protein Research, VIB, A. Baertsoenkaai 3, 9000 Ghent, Belgium.
Journal of Virological Methods
|July 22, 2008
Summary
The MAmmalian Protein-Protein Interaction Trap (MAPPIT) assay effectively detects interactions within the Human Immunodeficiency Virus (HIV) reverse transcriptase complex. This method shows promise as a novel screening tool for developing new anti-HIV compounds.
Area of Science:
- Virology
- Molecular Biology
- Drug Discovery
Background:
- High mutation rates in Human Immunodeficiency Virus (HIV) necessitate novel antiviral strategies.
- Developing compounds with alternative mechanisms of action is crucial to combat drug resistance.
Purpose of the Study:
- To investigate the dimerization of the HIV reverse transcriptase complex using the MAPPIT assay.
- To evaluate MAPPIT as a screening tool for anti-HIV drug discovery in intact human cells.
Main Methods:
- Utilized the MAmmalian Protein-Protein Interaction Trap (MAPPIT) assay to study protein-protein interactions.
- Applied MAPPIT to analyze the dimerization of HIV reverse transcriptase subunits (p66/p51 and p66/p66).
- Introduced mutations to confirm interaction specificity and treated cells with efavirenz to assess drug effects.
Main Results:
- Detected specific p66/p51 and p66/p66 interactions within the HIV reverse transcriptase complex.
- Efavirenz treatment increased the MAPPIT signal for p66/p51 interaction (EC50 = 64nM) and revealed p51/p51 homodimerization.
- Demonstrated context-dependent asymmetric contributions of the subunits.
Conclusions:
- MAPPIT is a highly efficient tool for studying protein-protein interactions in live human cells.
- MAPPIT successfully characterized HIV reverse transcriptase dimerization.
- MAPPIT serves as a novel platform for screening anti-HIV compounds targeting protein-protein interactions.
